To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene LASS2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
257 supporting clones for gene LASS2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AU120413 whole embryo, mainly body .a 1 to 731 11 to 741   tiling clone, capped   731/731
(100 %)
0 diff
(100 %id)
AK001105 whole embryo, mainly body .a 10 to 2073 20 to 2083   tiling clone, available from FLJ,   2064/2064
(100 %)
2 diff
(100.0 %id)
AU146484 whole embryo, mainly body .a 1553 to 2073 527 to 1       527/527
(100 %)
9 diff
(98.3 %id)
BM764143 myeloma .b 1 to 502 1 to 502   tiling clone,   502/502
(100 %)
1 diff
(99.9 %id)
NM_022075.3   .b 41 to 2505 1 to 2465   RefSeq,   2465/2465
(100 %)
1 diff
(100.0 %id)
BM561240 duodenal adenocarcinoma, cell line, small intestine .b 130 to 1000 1 to 872       872/992
(87 %)
9 diff
(99.1 %id)
CR996243 T-Lymphocytes .b 139 to 998 1 to 862       862/874
(98 %)
7 diff
(99.2 %id)
BX438716 placenta .b 167 to 1110 1 to 943       943/943
(100 %)
7 diff
(99.3 %id)
DB501337 hypothalamus .b 169 to 636 8 to 475       468/468
(100 %)
0 diff
(100 %id)
AL560908 B cells from Burkitt lymphoma .b 172 to 903 1 to 731       731/828
(88 %)
6 diff
(99.3 %id)
BM461394 eye, retinoblastoma .b 179 to 907 1 to 736       734/1106
(66 %)
11 diff
(99.1 %id)
BM461785 leiomyosarcoma, uterus .b 179 to 984 1 to 813       813/817
(99 %)
14 diff
(98.3 %id)
DR003824 Liver .b 179 to 947 1 to 769       769/773
(99 %)
7 diff
(99.1 %id)
AY091458   .b 180 to 2397 1 to 2216   tiling clone, AAA   2216/2216
(100 %)
6 diff
(99.8 %id)
AW674778 cervix .b 180 to 645 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
BQ686408 ductal carcinoma, cell line, Pancreas .b 181 to 853 1 to 672       672/922
(72 %)
13 diff
(98.6 %id)
AL554947 placenta, Placenta Cot 25-normalized .b 182 to 1224 1 to 1031       1031/1034
(99 %)
22 diff
(97.9 %id)
BG722174 testis .b 188 to 882 1 to 695       695/695
(100 %)
4 diff
(99.5 %id)
AL552875 placenta, Placenta Cot 25-normalized .b 197 to 1128 1 to 931       931/935
(99 %)
5 diff
(99.5 %id)
BE295824 muscle, rhabdomyosarcoma .b 197 to 900 1 to 697       697/699
(99 %)
17 diff
(97.6 %id)
BU844990 ovary, teratocarcinoma, cell line .b 197 to 1054 1 to 869       867/911
(95 %)
17 diff
(98.2 %id)
CT001891 T-Lymphocytes .b 204 to 973 1 to 771       771/773
(99 %)
3 diff
(99.7 %id)
BI335566 cervical carcinoma cell line, cervix .b 229 to 1031 48 to 856       809/860
(94 %)
13 diff
(98.5 %id)
BE906973 epithelioid carcinoma, Pancreas .b 236 to 1000 1 to 763       763/807
(94 %)
14 diff
(98.3 %id)
BE878179 large cell carcinoma, undifferentiated, lung .b 240 to 1001 1 to 765       765/917
(83 %)
16 diff
(98.3 %id)
BG702233 brain, hippocampus .b 245 to 1018 1 to 770       770/770
(100 %)
8 diff
(99.0 %id)
BU164844 epithelioid carcinoma, Pancreas .b 248 to 1104 1 to 866       866/866
(100 %)
14 diff
(98.4 %id)
BQ440246 melanotic melanoma, skin .b 249 to 1075 1 to 836       836/911
(91 %)
11 diff
(98.8 %id)
AL525448 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 258 to 1236 1 to 972       972/1072
(90 %)
10 diff
(99.1 %id)
TI_44167420   .b 266 to 1080 73 to 893       821/1087
(75 %)
25 diff
(97.8 %id)
BI549290 brain, hippocampus .b 272 to 1080 1 to 814       814/1008
(80 %)
23 diff
(97.8 %id)
AF177338   .b 273 to 2397 1 to 2123   AAA   2123/2123
(100 %)
6 diff
(99.8 %id)
DA373181 thalamus .b 275 to 897 2 to 624   capped   623/623
(100 %)
0 diff
(100 %id)
BX360205 Placenta Cot 25-normalized .b 281 to 1313 1 to 1030       1030/1030
(100 %)
5 diff
(99.6 %id)
BE908221 epithelioid carcinoma, Pancreas .b 282 to 1001 1 to 718       718/817
(87 %)
16 diff
(98.1 %id)
CT003937 T-Lymphocytes .b 284 to 1223 1 to 940       940/940
(100 %)
0 diff
(100 %id)
BF970122 adrenal cortex carcinoma, cell line, adrenal gland .b 285 to 1001 28 to 740       713/1032
(69 %)
26 diff
(97.5 %id)
DA261769 caudate nucleus .b 286 to 832 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
TI_57177399   .b 287 to 1116 63 to 893       831/897
(92 %)
15 diff
(98.4 %id)
DA543433   .b 289 to 838 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BQ221150 large cell carcinoma, lung .b 289 to 1000 1 to 711       711/917
(77 %)
12 diff
(98.7 %id)
BE897297 melanotic melanoma, skin .b 290 to 997 1 to 710       710/885
(80 %)
12 diff
(98.7 %id)
BI830905 brain, medulla .b 292 to 1116 1 to 826       826/830
(99 %)
9 diff
(99.0 %id)
BU172122 melanotic melanoma, skin .b 292 to 998 27 to 735       709/923
(76 %)
11 diff
(98.9 %id)
CA392778 eye, RPE/choroid .b 293 to 876 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BQ644932 hepatocellular carcinoma, cell line, Liver .b 295 to 998 19 to 720       702/973
(72 %)
19 diff
(98.1 %id)
DA282840 corpus callosum .b 296 to 851 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BI911728 leukocyte .b 296 to 1175 1 to 891       891/929
(95 %)
26 diff
(97.3 %id)
TI_57233827   .b 296 to 1175 1 to 891       891/929
(95 %)
26 diff
(97.3 %id)
BG171105 hypernephroma, cell line, Kidney .b 301 to 1094 1 to 791       789/792
(99 %)
17 diff
(97.9 %id)
BE875897 large cell carcinoma, undifferentiated, lung .b 302 to 1000 1 to 697       697/865
(80 %)
12 diff
(98.7 %id)
BG742540 skin .b 305 to 1236 1 to 937       937/959
(97 %)
29 diff
(97.0 %id)
DA372764 thalamus .b 306 to 848 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA422377 cervix .b 306 to 871 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BC001357 Skin, melanotic melanoma. .b 307 to 2491 1 to 2183   tiling clone, available from MGC, AAA   2183/2183
(100 %)
5 diff
(99.8 %id)
BQ673270 epidermoid carcinoma, cell line, salivary gland .b 307 to 1219 1 to 918       918/918
(100 %)
8 diff
(99.2 %id)
BM802619 eye, retinoblastoma .b 308 to 1233 1 to 927       927/1117
(82 %)
10 diff
(99.2 %id)
CD656161 Embryonic Stem cells .b 308 to 1119 11 to 822       812/825
(98 %)
15 diff
(98.2 %id)
CD652137 Embryonic Stem cells .b 308 to 1064 11 to 761       751/800
(93 %)
15 diff
(98.2 %id)
AL523053 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 309 to 1153 1 to 845       845/845
(100 %)
1 diff
(99.9 %id)
BI757217 brain .b 309 to 1236 1 to 924       924/944
(97 %)
24 diff
(97.5 %id)
BU180987 large cell carcinoma, lung .b 309 to 1213 1 to 915       915/927
(98 %)
16 diff
(98.3 %id)
TI_57221523   .b 309 to 1236 70 to 993       924/1013
(91 %)
31 diff
(97.0 %id)
DA476023   .b 310 to 871 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BM922953 leukocyte .b 310 to 1314 4 to 1015       1012/1032
(98 %)
22 diff
(97.9 %id)
BQ878340 dorsal root ganglia .b 314 to 1175 1 to 863       863/863
(100 %)
2 diff
(99.8 %id)
BQ952702 carcinoma, cell line, Prostate .b 314 to 1120 1 to 822       822/986
(83 %)
28 diff
(97.2 %id)
DB494921 hypothalamus .b 320 to 807 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BM921802 pooled brain, lung, testis .b 320 to 1236 20 to 945       926/1021
(90 %)
27 diff
(97.4 %id)
AL537627 brain, fetal brain .b 321 to 1162 1 to 842       842/842
(100 %)
0 diff
(100 %id)
DA825598 pericardium .b 321 to 899 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BF207162 brain, neuroblastoma .b 323 to 997 1 to 671       671/672
(99 %)
16 diff
(97.7 %id)
AK290989   .b 326 to 1656 1 to 1331 V153A     1331/1331
(100 %)
3 diff
(99.8 %id)
DA283722 corpus callosum .b 326 to 906 2 to 582   capped   581/582
(99 %)
0 diff
(100 %id)
BE277209 melanotic melanoma, skin .b 326 to 1135 1 to 810       810/828
(97 %)
7 diff
(99.2 %id)
CF132147 Chondrosarcoma Lung Metastasis cell lines, lung .b 326 to 995 1 to 670       670/670
(100 %)
0 diff
(100 %id)
TI_159677886   .b 326 to 1302 51 to 1017       901/1094
(82 %)
17 diff
(98.5 %id)
BI669163 brain, hypothalamus .b 332 to 1084 1 to 754       754/754
(100 %)
9 diff
(98.9 %id)
CF594151 Human Placenta, placenta .b 333 to 1096 29 to 797       769/810
(94 %)
12 diff
(98.6 %id)
DA379104 thalamus .b 335 to 897 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
TI_44346211   .b 337 to 1084 84 to 832       749/832
(90 %)
11 diff
(98.7 %id)
DA251308 caudate nucleus .b 338 to 881 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA274202 corpus callosum .b 338 to 891 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA349841 substantia nigra .b 338 to 924 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA475499   .b 338 to 899 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA543639   .b 338 to 909 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BI868672 adenocarcinoma, cell line, Liver .b 340 to 1121 1 to 781       781/781
(100 %)
2 diff
(99.8 %id)
TI_57228253   .b 340 to 1121 57 to 837       781/781
(100 %)
2 diff
(99.8 %id)
BC010032 Kidney, renal cell adenocarcinoma .b 343 to 2397 1 to 2054   tiling clone, available from MGC, AAA   2054/2054
(100 %)
4 diff
(99.9 %id)
BE382572 brain, neuroblastoma .b 343 to 940 1 to 598       598/598
(100 %)
0 diff
(100 %id)
DA693204   .b 345 to 897 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DR004100 Liver .b 346 to 1126 1 to 780       780/780
(100 %)
5 diff
(99.4 %id)
AL554049 placenta, Placenta Cot 25-normalized .b 347 to 1382 1 to 1030       1030/1035
(99 %)
8 diff
(99.3 %id)
BE907655 epithelioid carcinoma, Pancreas .b 347 to 967 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BM805719 brain, hippocampus .b 349 to 1001 124 to 776       653/1147
(56 %)
9 diff
(99.3 %id)
CX872119 embryonic stem .b 370 to 1146 1 to 777       777/777
(100 %)
2 diff
(99.8 %id)
DA431365 colon .b 374 to 919 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AL562543 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1320 to 2390 1061 to 1   tiling clone,   1061/1065
(99 %)
21 diff
(98.1 %id)
AL576026 placenta, Placenta Cot 25-normalized .b 1412 to 2380 967 to 1       967/967
(100 %)
29 diff
(97.1 %id)
AL577544 placenta, Placenta Cot 25-normalized .b 1431 to 2362 946 to 18       929/983
(94 %)
15 diff
(98.5 %id)
AL576881 placenta, Placenta Cot 25-normalized .b 1477 to 2469 994 to 1       994/1005
(98 %)
15 diff
(98.6 %id)
AL566908 brain, fetal brain .b 1512 to 2355 868 to 28       841/868
(96 %)
0 diff
(100 %id)
AL582238 B cells from Burkitt lymphoma .b 1534 to 2387 854 to 7       848/974
(87 %)
0 diff
(100 %id)
AW673996 cervix .b 1933 to 2418 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
NM_181746.2   .c 1 to 2505 1 to 2505 exact RefSeq,   2505/2505
(100 %)
1 diff
(100.0 %id)
BQ050175 lymph, lymphoma, cell line .c 139 to 719 1 to 583   tiling clone,   583/1478
(39 %)
16 diff
(99.0 %id)
BU543940 carcinoma, cell line, Prostate .c 212 to 1111 1 to 910       910/925
(98 %)
16 diff
(98.3 %id)
DB486512 hypothalamus .c 221 to 628 1 to 409       409/412
(99 %)
5 diff
(98.8 %id)
AL711029 human skeletal muscle .c 233 to 844 1 to 612       612/612
(100 %)
0 diff
(100 %id)
DA019883   .c 238 to 729 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
DA019933   .c 238 to 813 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CF619392 Pooled Chondrosarcoma Tumor cells .c 241 to 1077 1 to 841       841/851
(98 %)
14 diff
(98.4 %id)
BM907435 large cell carcinoma, lung .c 245 to 1088 1 to 850       850/949
(89 %)
14 diff
(98.6 %id)
BQ219926 epithelioid carcinoma, Pancreas .c 265 to 1133 1 to 878       878/891
(98 %)
10 diff
(98.9 %id)
DA669304 esophagus .c 271 to 840 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BQ215360 melanotic melanoma, skin .c 277 to 998 1 to 726       726/933
(77 %)
14 diff
(98.5 %id)
TI_57196589   .c 298 to 1089 34 to 823       790/823
(95 %)
18 diff
(97.9 %id)
BI818678 pooled brain, lung, testis .c 301 to 1089 1 to 787       787/787
(100 %)
13 diff
(98.4 %id)
CV028290 mixed .c 388 to 1045 1 to 658       658/658
(100 %)
4 diff
(99.4 %id)
TI_1948076874   .c 388 to 1030 136 to 778   fully sequenced,   644/779
(82 %)
6 diff
(99.3 %id)
TI_1948076876   .c 388 to 937 141 to 689   fully sequenced,   550/690
(79 %)
6 diff
(99.2 %id)
TI_1948077041   .c 388 to 937 134 to 683   fully sequenced,   551/684
(80 %)
6 diff
(99.2 %id)
TI_1948077043   .c 388 to 937 139 to 688   fully sequenced,   551/689
(79 %)
6 diff
(99.2 %id)
TI_1948077213   .c 388 to 1030 139 to 781   fully sequenced,   644/782
(82 %)
6 diff
(99.3 %id)
TI_1948077215   .c 388 to 937 138 to 687   fully sequenced,   551/688
(80 %)
6 diff
(99.2 %id)
TI_1948077382   .c 388 to 1030 131 to 773   fully sequenced,   644/774
(83 %)
6 diff
(99.3 %id)
TI_1948077384   .c 388 to 1030 134 to 776   fully sequenced, AAA   644/777
(82 %)
6 diff
(99.3 %id)
BI906856 leukocyte .c 394 to 1236 1 to 839       839/843
(99 %)
12 diff
(98.6 %id)
TI_57233328   .c 394 to 1236 101 to 939       839/943
(88 %)
16 diff
(98.4 %id)
BU902122 leiomyosarcoma, uterus .c 395 to 1316 1 to 929       929/1194
(77 %)
14 diff
(98.9 %id)
CA487305   .c 396 to 1234 25 to 869       845/869
(97 %)
26 diff
(97.1 %id)
TI_57190785   .c 423 to 1213 59 to 852       794/794
(100 %)
21 diff
(97.4 %id)
BM451302 eye, retinoblastoma .c 433 to 1377 1 to 961       961/1038
(92 %)
22 diff
(97.9 %id)
CX871507 embryonic stem .c 434 to 1274 1 to 841   tiling clone,   841/841
(100 %)
0 diff
(100 %id)
BQ225616 large cell carcinoma, lung .c 483 to 1345 1 to 879       879/888
(98 %)
38 diff
(95.8 %id)
BE272613 Kidney, renal cell adenocarcinoma .c 543 to 1119 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BU541400 carcinoma, cell line, Prostate .c 551 to 1440 1 to 893       893/893
(100 %)
4 diff
(99.6 %id)
DA599494   .c 587 to 1156 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CR984012 T-Lymphocytes .c 591 to 1416 1 to 827       827/827
(100 %)
1 diff
(99.9 %id)
TI_59393243   .c 595 to 1372 85 to 866       782/782
(100 %)
18 diff
(97.7 %id)
BM015124 breast, mammary adenocarcinoma, cell line .c 596 to 1372 1 to 781       781/781
(100 %)
18 diff
(97.7 %id)
BM553531 duodenal adenocarcinoma, cell line, small intestine .c 597 to 1314 1 to 728       728/1092
(66 %)
16 diff
(98.6 %id)
CD106460 brain, Pituitary .c 661 to 1533 22 to 900       879/901
(97 %)
19 diff
(97.9 %id)
BE162717 head_neck .c 663 to 1187 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CX760127 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 728 to 1464 1 to 737     Submitted on the opposite strand 737/740
(99 %)
2 diff
(99.8 %id)
ES308772 beard hair, skin .c 730 to 917 1 to 185       185/185
(100 %)
3 diff
(98.4 %id)
BQ267223 insulinoma, Pancreas .c 776 to 1202 1 to 427       427/427
(100 %)
3 diff
(99.3 %id)
DA008341 adipose .c 788 to 1353 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA753770   .c 788 to 1350 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BU170936 eye, retinoblastoma .c 803 to 1548 1 to 753       753/774
(97 %)
14 diff
(98.2 %id)
CX166339 human embryonic stem cells differentiated toan early endodermal cell type .c 833 to 1661 1 to 829   tiling clone,   829/829
(100 %)
2 diff
(99.8 %id)
AF189062 prostate cancer .c 834 to 2397 46 to 1612   AAA   1567/1612
(97 %)
33 diff
(98.0 %id)
BG910813 anaplastic oligodendroglioma with 1p/19qloss, brain .c 835 to 1735 1 to 908       908/925
(98 %)
23 diff
(97.6 %id)
BQ215160 melanotic melanoma, skin .c 838 to 1732 1 to 891       891/891
(100 %)
8 diff
(99.2 %id)
BU171593 melanotic melanoma, skin .c 838 to 1705 1 to 873       873/874
(99 %)
18 diff
(98.0 %id)
TI_1948076877   .c 876 to 1529 779 to 126   fully sequenced,   654/779
(83 %)
0 diff
(100 %id)
TI_1948077042   .c 876 to 1529 781 to 128   fully sequenced,   654/781
(83 %)
1 diff
(99.9 %id)
TI_1948077044   .c 876 to 1529 778 to 125   fully sequenced,   654/778
(84 %)
0 diff
(100 %id)
TI_1948077216   .c 876 to 1529 779 to 126   fully sequenced,   654/779
(83 %)
0 diff
(100 %id)
BM744561 stomach .c 881 to 1440 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BI223484 cervical carcinoma cell line, cervix .c 888 to 1600 1 to 707       707/707
(100 %)
11 diff
(98.5 %id)
BQ437940 melanotic melanoma, skin .c 891 to 1677 12 to 806       795/813
(97 %)
13 diff
(98.5 %id)
BI258752 cervical carcinoma cell line, cervix .c 898 to 1772 1 to 878       878/974
(90 %)
13 diff
(98.7 %id)
BI028067 marrow .c 938 to 1099 1 to 162       162/162
(100 %)
0 diff
(100 %id)
FN088621 breast carcinoma .c 941 to 1018 1 to 79       79/79
(100 %)
1 diff
(98.8 %id)
BU541092 carcinoma, cell line, Prostate .c 956 to 1659 154 to 863       710/1098
(64 %)
17 diff
(98.5 %id)
BQ957177 carcinoma, cell line, Prostate .c 965 to 1781 1 to 824       824/940
(87 %)
17 diff
(98.2 %id)
CN304537 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 966 to 1471 1 to 506       506/506
(100 %)
0 diff
(100 %id)
TI_1948076875   .c 969 to 1529 688 to 129   fully sequenced,   560/688
(81 %)
1 diff
(99.9 %id)
TI_1948077214   .c 969 to 1529 685 to 125   fully sequenced,   561/685
(81 %)
1 diff
(99.9 %id)
TI_1948077383   .c 969 to 1529 685 to 125   fully sequenced,   561/685
(81 %)
1 diff
(99.9 %id)
TI_1948077385   .c 969 to 1529 688 to 128   fully sequenced,   561/688
(81 %)
0 diff
(100 %id)
BG105773 adrenal cortex carcinoma, cell line, adrenal gland .c 1000 to 1726 1 to 724       724/747
(96 %)
15 diff
(98.0 %id)
CF264784 Brain glioblastoma .c 1003 to 1868 1 to 872       872/881
(98 %)
11 diff
(98.8 %id)
TI_57165045   .c 1008 to 1691 29 to 727       699/736
(94 %)
31 diff
(95.8 %id)
BQ923997 eye, normal pigmented retinal epithelium .c 1046 to 1995 1 to 956       956/957
(99 %)
34 diff
(96.5 %id)
CD515384 White Matter .c 1065 to 2017 27 to 981       955/985
(96 %)
32 diff
(96.8 %id)
BG034732 breast, mammary adenocarcinoma, cell line .c 1074 to 1868 1 to 796       796/889
(89 %)
25 diff
(97.2 %id)
BG026713 Bone, osteosarcoma, cell line .c 1083 to 1765 1 to 682       682/946
(72 %)
11 diff
(98.9 %id)
BG740934 skin .c 1111 to 1956 1 to 849       849/849
(100 %)
7 diff
(99.2 %id)
BM472770 melanotic melanoma, skin .c 1121 to 1840 1 to 738       738/991
(74 %)
28 diff
(97.2 %id)
BQ939045 sciatic nerve .c 1122 to 2029 42 to 968       927/968
(95 %)
32 diff
(96.7 %id)
BI870071 adenocarcinoma, cell line, Liver .c 1279 to 2119 1 to 838       838/842
(99 %)
11 diff
(98.7 %id)
TI_57229396   .c 1279 to 2119 85 to 922       838/842
(99 %)
11 diff
(98.7 %id)
TI_154189529   .c 1279 to 2221 50 to 978       929/1036
(89 %)
19 diff
(98.2 %id)
CF126527 Chondrosarcoma Lung Metastasis cell lines, lung .c 1280 to 1945 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
BG164337 hypernephroma, cell line, Kidney .c 1325 to 2094 1 to 765       765/944
(81 %)
26 diff
(97.3 %id)
BG708085 brain, hypothalamus .c 1326 to 2098 6 to 772       767/774
(99 %)
20 diff
(97.5 %id)
CD519088 White Matter .c 1328 to 2075 1 to 770       770/978
(78 %)
26 diff
(97.4 %id)
BG029922 breast, mammary adenocarcinoma, cell line .c 1351 to 2096 1 to 740       740/930
(79 %)
22 diff
(97.7 %id)
CF455443 peripheral nervous system .c 1372 to 2169 29 to 826       798/826
(96 %)
9 diff
(99.0 %id)
BM724936 eye, fetal eye .c 1372 to 1880 1 to 508   fully sequenced,   508/508
(100 %)
2 diff
(99.7 %id)
BU957205 adenocarcinoma, cell line, breast .c 1387 to 2250 1 to 883       883/949
(93 %)
32 diff
(96.7 %id)
BQ641380 eye, normal pigmented retinal epithelium .c 1388 to 2238 16 to 871       856/948
(90 %)
21 diff
(97.8 %id)
CX873684 embryonic stem .c 1390 to 2237 1 to 848   tiling clone,   848/848
(100 %)
1 diff
(99.9 %id)
BQ212936 melanotic melanoma, skin .c 1395 to 2195 1 to 813       813/844
(96 %)
18 diff
(97.9 %id)
BE787737 large cell carcinoma, lung .c 1401 to 2157 1 to 759       759/1025
(74 %)
22 diff
(97.9 %id)
BG911610 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1402 to 2038 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
AA459458 germinal center B cell .c 1452 to 1943 1 to 492       492/492
(100 %)
6 diff
(98.8 %id)
BM807237 duodenal adenocarcinoma, cell line, small intestine .c 1467 to 2382 1 to 928       928/1011
(91 %)
20 diff
(98.1 %id)
BI090390 cervix .c 1512 to 2196 1 to 686       686/686
(100 %)
2 diff
(99.8 %id)
BG618864 Liver .c 1533 to 2249 1 to 713       713/714
(99 %)
6 diff
(99.2 %id)
TI_227712771   .c 1534 to 2412 938 to 80   AAA   859/985
(87 %)
23 diff
(97.7 %id)
BE906874 epithelioid carcinoma, Pancreas .c 1550 to 2292 1 to 734       734/751
(97 %)
16 diff
(97.9 %id)
CN304546 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1570 to 2244 9 to 683       675/683
(98 %)
6 diff
(99.2 %id)
BU181991 eye, retinoblastoma .c 1571 to 2411 12 to 866   AAA   855/867
(98 %)
18 diff
(98.0 %id)
BI763319 pooled colon, kidney, stomach .c 1573 to 2381 1 to 809       809/859
(94 %)
6 diff
(99.4 %id)
BQ954019 sciatic nerve .c 1573 to 2359 23 to 819       797/1058
(75 %)
14 diff
(98.7 %id)
TI_57150152   .c 1573 to 2381 36 to 844       809/894
(90 %)
6 diff
(99.4 %id)
AI061649 Liver .c 1579 to 2224 8 to 653       646/653
(98 %)
0 diff
(100 %id)
CN304535 embryonic stem cells, DMSO-treated H9 cellline .c 1581 to 2221 1 to 641       641/641
(100 %)
5 diff
(99.3 %id)
CA453512 mixed (pool of 40 RNAs) .c 1589 to 2282 1 to 698       698/747
(93 %)
20 diff
(97.4 %id)
BU532876 mixed (pool of 40 RNAs) .c 1596 to 2347 1 to 764       764/764
(100 %)
16 diff
(98.0 %id)
BM272751 insulinoma, Pancreas .c 1597 to 2128 1 to 532     Submitted on the opposite strand 532/532
(100 %)
0 diff
(100 %id)
BE787034 large cell carcinoma, lung .c 1602 to 2358 1 to 748       748/749
(99 %)
15 diff
(98.0 %id)
W03816 liver and spleen .c 1619 to 2068 6 to 455   fully sequenced,   450/455
(98 %)
7 diff
(98.5 %id)
BE748679 bone marrow, from acute myelogenous leukemia .c 1631 to 2321 697 to 1       697/943
(73 %)
0 diff
(100 %id)
TI_154113040   .c 1639 to 2422 863 to 92   AAA   772/930
(83 %)
20 diff
(97.9 %id)
BU194966 melanotic melanoma, skin .c 1640 to 2485 1 to 856       856/900
(95 %)
16 diff
(98.3 %id)
CD675166 eye, lens .c 1661 to 2179 1 to 519       519/519
(100 %)
0 diff
(100 %id)
TI_149298141   .c 1687 to 2491 905 to 116       790/1034
(76 %)
0 diff
(100 %id)
BG109019 Bone, osteosarcoma, cell line .c 1690 to 2422 1 to 727   AAA   727/727
(100 %)
16 diff
(97.8 %id)
BQ233275 epithelioid carcinoma, Pancreas .c 1708 to 2415 1 to 705   AAA   705/705
(100 %)
2 diff
(99.8 %id)
BE882825 leiomyosarcoma, uterus .c 1709 to 2404 1 to 686       686/877
(78 %)
15 diff
(98.3 %id)
CR739051 uterus .c 1712 to 2250 1 to 539       539/539
(100 %)
0 diff
(100 %id)
CA426757 cell lines, Chondrosarcoma .c 1713 to 2425 731 to 19   tiling clone, AAA   713/713
(100 %)
1 diff
(99.9 %id)
TI_154035400   .c 1733 to 2494 834 to 79   AAA   756/918
(82 %)
14 diff
(98.5 %id)
CD742814 Alveolar Macrophage, lung .c 1741 to 2415 687 to 15   AAA   673/673
(100 %)
4 diff
(99.5 %id)
BU623905 cell lines, Enchondroma .c 1743 to 2491 765 to 19   AAA   747/747
(100 %)
3 diff
(99.6 %id)
BE906370 epithelioid carcinoma, Pancreas .c 1746 to 2406 1 to 657       657/659
(99 %)
10 diff
(98.5 %id)
BU625198 cell lines, Enchondroma .c 1750 to 2425 694 to 19   AAA   676/676
(100 %)
2 diff
(99.8 %id)
AA345236 gall bladder .c 1753 to 2066 1 to 314       314/314
(100 %)
0 diff
(100 %id)
BQ233443 epithelioid carcinoma, Pancreas .c 1774 to 2415 1 to 642   AAA   642/642
(100 %)
4 diff
(99.4 %id)
EL946719 eyeball .c 1797 to 2224 4 to 428       425/428
(99 %)
6 diff
(98.6 %id)
AA010750 heart .c 1830 to 2294 1 to 469   fully sequenced,   469/469
(100 %)
4 diff
(99.2 %id)
CA443969 Fibrosarcoma .c 1838 to 2494 675 to 19   tiling clone, AAA   657/657
(100 %)
1 diff
(99.9 %id)
BM680165 eye, fetal eye .c 1850 to 2491 657 to 19   fully sequenced, AAA   639/639
(100 %)
2 diff
(99.7 %id)
FN158003 breast carcinoma .c 1900 to 2014 1 to 115       115/115
(100 %)
2 diff
(98.3 %id)
TI_151736096   .c 1924 to 2415 584 to 95   AAA   490/490
(100 %)
11 diff
(97.8 %id)
AI889883 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1953 to 2419 467 to 3       465/467
(99 %)
0 diff
(100 %id)
BU734832 eye, lens .c 1983 to 2415 446 to 15   AAA   432/432
(100 %)
1 diff
(99.8 %id)
FN114007 breast carcinoma .c 1992 to 2110 1 to 114       114/114
(100 %)
5 diff
(95.7 %id)
BQ272476 insulinoma, Pancreas .c 2028 to 2491 479 to 19   AAA   461/461
(100 %)
2 diff
(99.6 %id)
N90187 liver and spleen .c 2038 to 2491 459 to 1   tiling clone, fully sequenced,   459/459
(100 %)
6 diff
(98.7 %id)
EC546243 Prostate .c 2055 to 2152 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
T34856 brain .c 2086 to 2316 1 to 231       231/231
(100 %)
0 diff
(100 %id)
FN095260 breast carcinoma .c 2088 to 2173 1 to 86       86/99
(86 %)
1 diff
(99.0 %id)
FN117008 breast carcinoma .c 2138 to 2215 1 to 77       77/78
(98 %)
3 diff
(96.2 %id)
BX392113 Neuroblastoma Cot 25-normalized .c 2148 to 2433 287 to 4       284/287
(98 %)
0 diff
(100 %id)
AI827150 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 2180 to 2425 272 to 26   AAA   247/247
(100 %)
12 diff
(95.2 %id)
AA465677 germinal center B cell .c 2223 to 2415 203 to 11   AAA   193/193
(100 %)
1 diff
(99.5 %id)
DV460832 cochlea, ear .c 2229 to 2362 1 to 134       134/134
(100 %)
0 diff
(100 %id)
BE962281 adenocarcinoma, colon .c 2245 to 2491 274 to 24   AAA   251/251
(100 %)
9 diff
(96.5 %id)
AA011178 heart .c 2264 to 2488 253 to 24   fully sequenced, AAA   230/230
(100 %)
2 diff
(99.2 %id)
BE617741 adenocarcinoma, colon .c 2265 to 2479 221 to 7       215/221
(97 %)
11 diff
(95.1 %id)
GD160308   .c 2419 to 2484 1 to 66       66/66
(100 %)
2 diff
(97.0 %id)
GD153746   .c 2420 to 2487 1 to 69   AAA   69/69
(100 %)
2 diff
(97.2 %id)
CX163616 human embryonic stem cells differentiated toan early endodermal cell type .d 1 to 896 8 to 903 K207Q tiling clone,   896/903
(99 %)
8 diff
(99.2 %id)
BJ990735 hepatoblastoma .e 1 to 588 10 to 600   tiling clone,   591/600
(98 %)
2 diff
(99.7 %id)
BF530075 anaplastic oligodendroglioma with 1p/19qloss, brain .e 623 to 1269 11 to 653   tiling clone,   643/653
(98 %)
8 diff
(98.8 %id)
AA283135 germinal center B cell .e 1114 to 1548 1 to 437       437/437
(100 %)
2 diff
(99.6 %id)
DR422348 eye, Pterygium .e 1135 to 1672 1 to 538       538/538
(100 %)
3 diff
(99.5 %id)
BE747999 bone marrow, from acute myelogenous leukemia .e 1203 to 1883 1 to 673   tiling clone,   673/673
(100 %)
12 diff
(98.3 %id)
BQ220125 large cell carcinoma, lung .e 1204 to 2075 1 to 883       883/897
(98 %)
24 diff
(97.4 %id)
BI334968 cervical carcinoma cell line, cervix .e 1224 to 2104 1 to 880       880/896
(98 %)
21 diff
(97.7 %id)
BI333770 cervical carcinoma cell line, cervix .e 1224 to 2112 1 to 893       893/894
(99 %)
10 diff
(98.9 %id)
CB055020 brain, glioblastoma (pooled) .e 1231 to 1539 1 to 309       309/309
(100 %)
5 diff
(98.4 %id)
DR762342 embryonic stem .e 1240 to 2012 1 to 772   tiling clone,   772/772
(100 %)
3 diff
(99.7 %id)
BM729002 eye, fetal eye .e 1257 to 1872 1 to 613   fully sequenced,   613/613
(100 %)
6 diff
(99.1 %id)
TI_154180212   .e 1287 to 2120 73 to 907       835/838
(99 %)
14 diff
(98.4 %id)
ES315259 occipital scalp hair, skin .e 1292 to 1478 1 to 187       187/187
(100 %)
0 diff
(100 %id)
BM681949 eye, fetal eye .e 1842 to 2489 659 to 15   fully sequenced, AAA   645/645
(100 %)
4 diff
(99.4 %id)
CB055019 brain, glioblastoma (pooled) .e 1881 to 2573 713 to 24   tiling clone, AAA   690/690
(100 %)
3 diff
(99.6 %id)
BJ990736 hepatoblastoma .e 1927 to 2469 540 to 1   tiling clone,   540/540
(100 %)
2 diff
(99.7 %id)
BG724089 testis .f 1 to 660 1 to 663   tiling clone,   663/663
(100 %)
13 diff
(98.1 %id)
DB482225 hippocampus .f 29 to 506 1 to 478   tiling clone,   478/478
(100 %)
0 diff
(100 %id)
BI458845 testis .f 88 to 741 1 to 660 L67S L68* tiling clone,   659/660
(99 %)
17 diff
(97.5 %id)
CN481953 eye .f 119 to 715 1 to 597   tiling clone,   597/597
(100 %)
1 diff
(99.9 %id)
DA385493 thalamus .g 1 to 593 2 to 594 exact tiling clone, capped   593/593
(100 %)
0 diff
(100 %id)
BE171468 head_neck .h-u 1 to 174 1 to 174 E2G tiling clone,   174/174
(100 %)
4 diff
(97.8 %id)
BY995631   Gene LASS2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI